Online inquiry

IVTScrip™ mRNA-Human ARL4C, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28642MR)

This product GTTS-WK28642MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARL4C protein. This product can be used in Effector CD8+ memory T (Tem) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001282431.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 10123
UniProt ID P56559
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARL4C, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28642MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK8776MR IVTScrip™ mRNA-Human ABI3BP, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ABI3BP
GTTS-WK23505MR IVTScrip™ mRNA-Human ARHGDIB, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGDIB
GTTS-WK12277MR IVTScrip™ mRNA-Human AES, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AES
GTTS-WK23256MR IVTScrip™ mRNA-Human ARMC5, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARMC5
GTTS-WK17324MR IVTScrip™ mRNA-Human ANKRD39, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ANKRD39
GTTS-WK10480MR IVTScrip™ mRNA-Human AFAP1L2, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA AFAP1L2
GTTS-WK22963MR IVTScrip™ mRNA-Human ARNTL, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARNTL
GTTS-WK13882MR IVTScrip™ mRNA-Human ABRACL, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ABRACL
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →